Near-Sun observations of an F-corona decrease and K-corona fine structure.

Remote observations of the solar photospheric light scattered by electrons (the K-corona) and dust (the F-corona or zodiacal light) have been made from the ground during eclipses1 and from space at distances as small as 0.3 astronomical units2-5 to the Sun. Previous observations6-8 of dust scattering have not confirmed the existence of the theoretically predicted dust-free zone near the Sun9-11. The transient nature of the corona has been well characterized for large events, but questions still remain (for example, about the initiation of the corona12 and the production of solar energetic particles13) and for small events even its structure is uncertain14. Here we report imaging of the solar corona15 during the first two perihelion passes (0.16-0.25 astronomical units) of the Parker Solar Probe spacecraft13, each lasting ten days. The view from these distances is qualitatively similar to the historical views from ground and space, but there are some notable differences. At short elongations, we observe a decrease in the intensity of the F-coronal intensity, which is suggestive of the long-sought dust free zone9-11. We also resolve the fine-scale plasma structure of very small eruptions, which are frequently ejected from the Sun. These take two forms: the frequently observed magnetic flux ropes12,16 and the predicted, but not yet observed, magnetic islands17,18 arising from the tearing-mode instability in the current sheet. Our observations of the coronal streamer evolution confirm the large-scale topology of the solar corona, but also reveal that, as recently predicted19, streamers are composed of yet smaller substreamers channelling continual density fluctuations at all visible scales.

The FIELDS Instrument Suite for Solar Probe Plus: Measuring the Coronal Plasma and Magnetic Field, Plasma Waves and Turbulence, and Radio Signatures of Solar Transients.

NASA's Solar Probe Plus (SPP) mission will make the first in situ measurements of the solar corona and the birthplace of the solar wind. The FIELDS instrument suite on SPP will make direct measurements of electric and magnetic fields, the properties of in situ plasma waves, electron density and temperature profiles, and interplanetary radio emissions, amongst other things. Here, we describe the scientific objectives targeted by the SPP/FIELDS instrument, the instrument design itself, and the instrument concept of operations and planned data products.

Update of the Photometric Calibration of the LASCO-C2 Coronagraph Using Stars.

We present an update to the photometric calibration of the LASCO-C2 coronagraph onboard the SOHO spacecraft. We obtained the new calibration using data from the beginning of the mission in 1996 until 2013. We re-examined the LASCO-C2 photometric calibration by comparing the past three calibrations and the present calibration with the goal of validating an in-flight calibration. We find a photometric calibration factor (PCF) that is very similar to the factor recently published in Gardès, Lamy, and Llebaria (Solar Phys.283, 667, 2013), which calculated a calibration between 1996 and 2009. The average of our PCF between 1999 and 2009 is the same, within our margin of error, as the average given by Gardès, Lamy, and Llebaria (Solar Phys.283, 667, 2013) during the same time period. However, we find a different evolution of the calibration over the lifetime of the LASCO-C2 instrument compared with past results. We find that the sensitivity of the instrument is decreasing by a constant 0.20 [±0.03] % per year. We also find no significant difference in the signal degradation before and after the SOHO interruption. We discuss the effects of this new PCF on the calibrated data set and the potential impact on scientific results derived from the previous calibration.

Tonabersat, a gap-junction modulator: efficacy and safety in two randomized, placebo-controlled, dose-ranging studies of acute migraine.

Tonabersat is a novel benzopyran derivative that blocks the cortical spreading depression proposed to be associated with migraine attacks. The ability of single oral doses of 15, 25, 40 and 80 mg of tonabersat to relieve the symptoms of moderate to severe migraine was evaluated in 859 migraineurs enrolled in two dose-ranging, double-blind, randomized, placebo-controlled, parallel-group trials, one international and the other North American. In the international study, significantly more patients given tonabersat than given placebo experienced relief of headache pain at 2 h (15 mg, 36.8%; 40 mg, 40.7%), the principal efficacy variable, and at 4 h (40 mg, 63.0%) and complete abolition of headache at 4 h (40 mg, 34.3%). None of the primary or secondary efficacy variables indicated significant differences between tonabersat and placebo in the North American study. Tonabersat was generally well tolerated, with dizziness and nausea the most common side-effects. Serious adverse events were uncommon, and no patient withdrew from either study because of adverse events. These results suggest a possible interplay between tonabersat pharmacokinetics (the relatively long time required to reach maximum plasma concentrations) and patient characteristics (previous triptan exposure) in the management of acute migraine attacks. Based on the pharmacokinetics and actions on cortical spreading depression, tonabersat may have potential value in migraine prophylaxis.

Symptomatic hypotension during arm cycle ergometry exercise: a report of five cases.

We report five cases of vasovagal and vasodepressor syncope or near-syncope that occurred during arm cycle ergometry. In each case, arm exercise in the seated position had been performed immediately after dynamic leg exercise. A likely mechanism involves a decrease in preload from venous pooling of blood in the lower extremities after leg exercise, and excessive stimulation of ventricular mechanoreceptors with resultant sympatho-inhibition and enhanced vagal tone. Four of the cases occurred early in the course of the exercise program, between the 8th and 10th sessions. The single case of true syncope occurred in a patient not receiving a beta-receptor blocking medication. No further events occurred when the exercise regimen was changed such that arm cycle ergometry was performed before leg exercise. We recommend that when arm ergometry is incorporated into an exercise program: (1) a cool-down period of exercise is performed after dynamic leg exercise, or (2) arm exercise is performed before dynamic leg exercise. These maneuvers may preclude the occurrence of symptomatic hypotension.

Papillary fibroelastoma: increasing recognition of a surgical disease.

Papillary fibroelastomas are uncommon benign tumors usually involving the heart valves, which historically have been diagnosed at autopsy. With the advent of echocardiography, however, the number of patients diagnosed in life has increased. Papillary fibroelastomas represent a surgically treatable cause of cerebrovascular and cardiovascular ischemia and infarction making their identification clinically important. We report three unusual cases of papillary fibroelastoma; two patients presenting with symptoms of cerebrovascular ischemia and one presenting with myocardial infarction. We also present a comprehensive review of the literature and provide a compilation of all case reports to date.

A longitudinal study of psychological distress in women with breast symptoms.

The aim of the study was to measure psychological distress in women with breast symptoms over a period of three months following an outpatient appointment at a rapid access symptomatic breast clinic. Women were recruited (N = 150) at the weekly clinic and psychological distress was measured using the Hospital Anxiety and Depression Scale, the General Health Questionnaire-12 and the Spielberger State-Trait Anxiety Inventory. Information on age and diagnosis was collected from medical notes. Measures were repeated at two weeks and at three months. Participants were divided into three diagnostic categories: B 1 (benign diagnosis at clinic); B2 (benign after further investigations); and M (breast cancer). Overall, scores of anxiety and GHQ-12 decreased significantly during the follow- up period. However, participants in the B2 group remained significantly more distressed than the rest of the sample throughout the experimental period. Depression remained within the normal range throughout the follow-up period for all categories. The study suggests a relationship between symptomatic breast disease and psychological distress.

Effect of epinephrine on intrathecal fentanyl analgesia in patients undergoing postpartum tubal ligation.

Eighty women receiving spinal anesthesia for postpartum tubal ligation were entered into a double-blind, randomized protocol studying the effects of epinephrine on intrathecal fentanyl-induced postoperative analgesia. All patients received 70 mg hyperbaric lidocaine with either 0.2 mg epinephrine (LE), 10 micrograms fentanyl (LF), epinephrine and fentanyl (LFE), or 0.4 ml saline (L). Onset and regression of anesthesia, degree of intraoperative comfort, incidence of pruritus, and extent of postoperative analgesia were evaluated. The simultaneous administration of epinephrine and fentanyl prolonged the duration of complete analgesia (137 +/- 47 min (LFE); 76 +/- 32 min (LE); 85 +/- 44 min (LF); 65 +/- 36 min (L)) and the duration of effective analgesia (562 +/- 504 min (LFE); 227 +/- 201 min (LE); 203 +/- 178 min (LF); 198 +/- 342 min (L)). Administration of epinephrine decreased the incidence of pruritus associated with intrathecal fentanyl (1/18 (LFE); 1/21 (LE); 8/19 (LF); 2/19 (L)).

Microrisks for medical decision analysis.

Many would agree on the need to inform patients about the risks of medical conditions or treatments and to consider those risks in making medical decisions. The question is how to describe the risks and how to balance them with other factors in arriving at a decision. In this article, we present the thesis that part of the answer lies in defining an appropriate scale for risks that are often quite small. We propose that a convenient unit in which to measure most medical risks is the microprobability, a probability of 1 in 1 million. When the risk consequence is death, we can define a micromort as one microprobability of death. Medical risks can be placed in perspective by noting that we live in a society where people face about 270 micromorts per year from interactions with motor vehicles. Continuing risks or hazards, such as are posed by following unhealthful practices or by the side-effects of drugs, can be described in the same micromort framework. If the consequence is not death, but some other serious consequence like blindness or amputation, the microrisk structure can be used to characterize the probability of disability. Once the risks are described in the microrisk form, they can be evaluated in terms of the patient's willingness-to-pay to avoid them. The suggested procedure is illustrated in the case of a woman facing a cranial arteriogram of a suspected arterio-venous malformation. Generic curves allow such analyses to be performed approximately in terms of the patient's sex, age, and economic situation. More detailed analyses can be performed if desired. Microrisk analysis is based on the proposition that precision in language permits the soundness of thought that produces clarity of action and peace of mind.

Correlation between effects of acute acetazolamide administration to mice on electroshock seizure threshold and maximal electroshock seizure pattern, and on carbonic anhydrase activity in subcellular fractions of brain.

The relationships between inhibition of carbonic anhydrase (CA) activity in cytoplasmic, microsomal, and myelin subcellular fractions obtained from cerebral cortex, subcortex, and cerebellum and electroshock seizure threshold (EST) and modification of the extension/flexion (E/F) ratio following maximal electroshock seizures (MES) were ascertained in Swiss-Webster mice given 40 and 200 mg/kg acetazolamide. The parameters were determined at 1, 4, and 24 h after administration of acetazolamide. The results showed that changes in the E/F ratio induced by acetazolamide correlated linearly (r = 0.90) with changes in CA activity in the cytoplasm of the subcortex. However, there was an inverse power function correlation (r = 0.92) between EST and CA activity in the myelin fraction of the cerebral cortex. The time course of acetazolamide inhibition of CA activity in these two fractions also paralleled the time course of its effects on EST and E/F ratio. Thus, acetazolamide decreases susceptibility to seizures (raises EST) by inhibiting myelin CA and prevents spread of seizure activity by inhibiting CA in the cytoplasm of glial cells. The CO2 that accumulates as a result of CA inhibition in these two fractions causes profound changes in brain function.

Observations of a comet on collision course with the sun.

A brilliant new comet (1979 XI: Howard-Koomen-Michels) was discovered in data from the Naval Research Laboratory's orbiting SOLWIND coronagraph. An extensive sequence of pictures, telemetered from the P78-1 satellite, shows the coma, accompanied by a bright and well-developed tail, passing through the coronagraph's field of view at afew million kilometers from the sun. Preliminary orbital calculations based on the observed motion of the comet's head and morphology of the tail indicate that this previously unreported object is a sungrazing comet and may be one of the group of Kreutz sungrazers. It appears from the data that the perihelion distance was less than 1 solar radius, so that the cometary nucleus encountered dense regions of the sun's atmosphere, was completely vaporized, and did not reappear after the time of closest approach to the sun. After this time, however, cometary debris, scattered into the ambient solar wind, caused a brightening of the corona over one solar hemisphere and to heliocentric distances of 5 to 10 solar radii.

Affinity labeling of a cysteine at or near the catalytic center of Escherichia coli B DNA-dependent RNA polymerase.

9-beta-D-Arabinofuranosyl-6-thiopurine was used to affinity label DNA-dependent RNA polymerase isolated from Escherichia coli B. This substrate analogue displayed competitive type inhibition which could be reversed by addition of a thiol reagent, such as dithiothreitol, while exposure to hydrogen peroxide, a mild oxidizing agent, caused an increase in both the inhibitory and enzyme binding capability of arabinofuranosyl thiopurine. Chromatographic analysis of the products obtained by pronase digestion of the 9-beta-D-arabinofuranosyl-6-[35S]thiopurine-enzyme complex suggests that disulfide bond formation occurs between the inhibitor and a cysteine residue located in or near the active center of the enzyme. In addition, polyacrylamide gel electrophoresis indicated that the arabinofuranosyl thiopurine moeity was bound to the beta' subunit of the enzyme.

The effect of verapamil on the gastrocnemius and soleus muscles of the cat in vivo.

The effects of verapamil on the force of contraction of soleus and gastrocnemius muscles of the cat were examined in vivo. The rapid intra-arterial administration of verapamil (100-800 micrograms/kg) produced a dose-dependent increase in the contractile force of soleus and gastrocnemius muscles stimulated supramaximally via their nerves. Verapamil also potentiated twitch tension in d-tubocurarine-treated, directly stimulated soleus preparations. This agent had no effect, however, on the contractile force of 14- to 16-day chronically denervated, directly stimulated soleus muscle. Verapamil (400 microgram/kg, i.a.) also produced a significant increase in muscle action potential duration while having no effect on amplitudes, rise times or resting membrane potential. It is concluded that verapamil acts directly on innervated skeletal muscle to increase muscle force and it is suggested that the probable site of action is at the muscle membrane.

Subunit localizations of zinc(II) in DNA-dependent RNA polymerase from Escherichia coli B.

RNA Polymerase holoenzyme and core enzyme from Escherichia coli B have been shown to contain two zinc ions. Flameless atomic absorption spectroscopy of the isolated core subunits indicated that one zinc ion is localized on the beta subunit and the other is bound on the beta' subunit. Atomic fluorescence spectroscopy showed that prolonged dialysis of the metalloenzyme against 0.01 M o-phenanthroline resulted in the removal of both zinc(II) ions with accompanying loss of enzymatic activity. The activity of the apoenzyme was observed to be completely restored by readdition of zinc(II) and partially restored by cobalt(II).

Mechanism of action of tetra-mu-carboxylatodirhodium(II) in L1210 tumor suspension culture.

The effect of tetrakis-mu-methoxyacetato, tetra-mu-acetato, tetra-mu-propionato, and tetra-mu-butyratodirhodium(II) on the proliferation and macromolecular synthesis of leukemia L1210 cells in suspension culture was evaluated. The cytotoxicity of these dimeric rhodium(II) complexes to tumor cells in suspension culture follows the same trend as observed in vivo, i.e., butyrato greater than propionato greater than acetato greater than methoxyacetato. The cellular synthesis of DNA and protein was found to be strongly inhibited by tetra-mu-propionatodirhodium(II), whereas minimal inhibition of RNA synthesis was observed. Flow microfluorometric analysis of the drug-treated cells revealed an arrest of cellular development during the G2 phase of the cell cycle. The inhibition of DNA synthesis was attributed at least in part to the arrest in G2 which is consistent with the observed inhibition of protein synthesis.

Hydrophobicity of several rhodium(II) carboxylates correlated with their biologic activity.

Rhodium(II) carboxylates differ greatly in antitumor activity and toxicity depending on the properties of the carboxylate group (methoxyacetate, propionate, butyrate, etc.) involved. The solubility characteristics of rhodium(II) carboxylates correlate well with both the antitumor activity and toxicity that these compounds display. The amount of rhodium which is adsorbed by tumor cells in vitro also correlates with the partition coefficient of the rhodium(II) compounds studied. Survival and toxicity studies show rhodium(II) pentanoate to possess the highest therapeutic index against the Ehrlich ascites tumor strain and also show that lengthening the carboxylate R chain beyond the pentanoate reduces the drugs' therapeutic efficacy.

The interaction of rhodium(II) carboxylates with enzymes.

The effect of rhodium(II) acetate, propionate, and methoxyacetate on the activity of 17 enzymes was evaluated. The enzymes were preincubated with the rhodium(II) complexes in order to detect irreversible inhibition. All enzymes that have essential sulfhydryl groups in or near their active site were found to be irreversibly inhibited. Those enzymes without essential sulfhydryl groups were not affected. In each case, the rate of inactivation closely paralleled the observed toxicity and antitumor activity of rhodium(II) carboxylates; that is, rhodium(II) propionate greater than rhodium(II) acetate greater than rhodium(II) methoxyacetate. In addition, those enzymes that have been demonstrated to be most sensitive to established sulfhydryl inhibitors, such as glyceraldehyde-3-phosphate dehydrogenase, were also most sensitive to rhodium(II) carboxylate inactivation. Proton nuclear magnetic resonance measurements made during the titration of rhodium(II) acetate with cysteine showed that breakdown of the carboxylate cage occurred as a result of reaction with this sulfhydryl-containing amino acid.